Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of Docetaxel - Carboplatin As Second Line Treatment in Patients with Refractory or Relapsed Small Cell Lung Cancer

NCT00686985 is registered in ClinicalTrials.gov with Dr. B. Biesma as lead sponsor.

NCT NCT00686985
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00686985 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of Docetaxel - Carboplatin As Second Line Treatment in Patients with Refractory or Relapsed Small Cell Lung Cancer
Lead sponsor
Dr. B. Biesma
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2007
Completion date
July 31, 2012
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

small cell lung cancer